Evelo Biosciences Sees Unusually Large Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading on Wednesday. Stock traders purchased 1,885 put options on the stock. This is an increase of approximately 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Price Performance

Evelo Biosciences stock opened at $0.00 on Thursday. The firm has a market capitalization of $5,694.90, a PE ratio of 0.00 and a beta of 1.58. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $3.21. The firm’s 50-day simple moving average is $0.02 and its 200 day simple moving average is $0.04.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.